<DOC>
	<DOCNO>NCT02473120</DOCNO>
	<brief_summary>The purpose study determine frequency ESR1 mutation Digital PCR patient metastatic breast cancer .</brief_summary>
	<brief_title>Study ESR1 Mutations Metastatic Breast Cancer</brief_title>
	<detailed_description>Breast cancer common cancer woman . Aromatase inhibitor demonstrate real efficacy however resistance treatment exist . ESR1 mutation appear like involve mechanism resistance aromatase inhibitor treatment . The purpose study determine frequency ESR1 mutation Digital PCR patient metastatic breast cancer . The significance Digital PCR technique determine first plasma issue healthy volunteer . At initiation aromatase inhibitor treatment patient metastatic breast cancer include study . During follow-up visit every 3 month ) , status towards disease collect plasma collect . When patient progress clinically radiologically plasma concomitant progression analyse Digital PCR detect ESR1 mutation . The patient follow 2 year .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Aromatase Inhibitors</mesh_term>
	<criteria>Woman age superior 18 year old Inform consent sign Metastatic breast cancer locoregionnaly advance breast cancer Inoperable With indication treat aromatase inhibitor Treatment aromatase inhibitor innitiated inclusion least 6 month inclusion stable disease Without precedent treatment treatment chemotherapy/tamoxifen/faslodex aromatase inhibitor adjuvant treatment time frame 2 year last treatment aromatase inhibitor metastatic evolution Treatment aromatase inhibitor alone combination target therapy ( trastuzumab +/ pertuzumab , bevacizumab , everolimus ) No inform consent sign Patient guardianship , curatorship Psychosocial disorder No affiliate beneficiary social benefit system</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>metastatic</keyword>
	<keyword>ESR1</keyword>
	<keyword>aromatase inhibitor</keyword>
	<keyword>breast cancer</keyword>
</DOC>